Highlights & Basics
- Symptoms of obstructive sleep apnea (OSA) include loud snoring, gasping during sleep, apneas, unrefreshing sleep, and excessive daytime sleepiness.
- Obesity, retro- or micrognathia, oropharyngeal narrowing, and macroglossia are common physical features.
- Diagnosis is established using clinical evaluation plus polysomnography or portable sleep tests.
- Positive airway pressure or oral appliances are noninvasive treatment options.
- In patients unable to adhere to medical therapy or with discrete anatomic sites of obstruction, soft tissue and/or skeletal surgery may be selected for treatment of obstructive sleep apnea.
Quick Reference
History & Exam
Key Factors
Other Factors
Diagnostics Tests
Treatment Options
Definition
Epidemiology
Etiology
Pathophysiology
Citations
American Academy of Sleep Medicine. The AASM International classification of sleep disorders - third edition, text revision (ICSD-3-TR). Jun 2023 [internet publication].[Full Text]
Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017 Mar 15;13(3):479-504.[Abstract][Full Text]
Patil SP, Ayappa IA, Caples SM, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine clinical practice guideline. Sleep. 2019 Feb 15;15(2):335-43. [Abstract][Full Text]
Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021 Jul 20;144(3):e56-67.[Abstract][Full Text]
Ramar K, Dort LC, Katz SG, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015 Jul 15;11(7):773-827. [Abstract][Full Text]
1. American Academy of Sleep Medicine. The AASM International classification of sleep disorders - third edition, text revision (ICSD-3-TR). Jun 2023 [internet publication].[Full Text]
2. Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-98.[Abstract][Full Text]
3. Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020 Apr 14;323(14):1389-400.[Abstract]
4. Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013 May 1;177(9):1006-14.[Abstract][Full Text]
5. Redline S, Tishler PV, Hans MG, et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med. 1997 Jan;155(1):186-92.[Abstract]
6. Ruiter ME, DeCoster J, Jacobs L, et al. Sleep disorders in African Americans and Caucasian Americans: a meta-analysis. Behav Sleep Med. 2010;8(4):246-59.[Abstract]
7. Rosen CL, Larkin EK, Kirchner HL, et al. Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity. J Pediatr. 2003 Apr;142(4):383-9.[Abstract]
8. Dudley KA, Patel SR. Disparities and genetic risk factors in obstructive sleep apnea. Sleep Med. 2016 Feb;18:96-102.[Abstract][Full Text]
9. Mirrakhimov AE, Sooronbaev T, Mirrakhimov EM. Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature. BMC Pulm Med. 2013 Feb 23;13:10.[Abstract][Full Text]
10. Thornton JD, Dudley KA, Saeed GJ, et al. Differences in symptoms and severity of obstructive sleep apnea between black and white patients. Ann Am Thorac Soc. 2022 Feb;19(2):272-8.[Abstract][Full Text]
11. Sutherland K, Keenan BT, Bittencourt L, et al. A global comparison of anatomic risk factors and their relationship to obstructive sleep apnea severity in clinical samples. J Clin Sleep Med. 2019 Apr 15;15(4):629-39.[Abstract][Full Text]
12. Chang JL, Goldberg AN, Alt JA, et al. International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2023 Jul;13(7):1061-482.[Abstract][Full Text]
13. Senaratna CV, Perret JL, Lodge CJ, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017 Aug;34:70-81.[Abstract]
14. Au CT, Zhang J, Cheung JYF, et al. Familial aggregation and heritability of obstructive sleep apnea using children probands. J Clin Sleep Med. 2019 Nov 15;15(11):1561-70.[Abstract][Full Text]
15. Mathur R, Douglas NJ. Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med. 1995 Feb 1;122(3):174-8.[Abstract]
16. Redline S. Genetics of obstructive sleep apnea. In: Kryger MH, Roth T, and Dement WC, eds. Principles and practice of sleep medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:1013-22.
17. Lowe AA, Fleetham JA, Adachi S, et al. Cephalometric and computed tomographic predictors of obstructive sleep apnea severity. Am J Orthod Dentofacial Orthop. 1995 Jun;107(6):589-95.[Abstract]
18. Schwab RJ, Pasirstein M, Pierson R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric MRI. Am J Respir Crit Care Med. 2003 Sep 1;168(5):522-30.[Abstract][Full Text]
19. Edstrom L, Larsson H, Larsson L. Neurogenic effects on the palatopharyngeal muscle in patients with obstructive sleep apnoea: a muscle biopsy study. J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):916-20.[Abstract][Full Text]
20. Fridberg D. Heavy snorer's disease: a progressive local neuropathy. Acta Otolaryngol. 1999;119(8):925-33.[Abstract]
21. Schwab RJ, Gefter WB, Hoffman EA, et al. Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis. 1993 Nov;148(5):1385-400.[Abstract]
22. Isono S, Remmers JE, Tanaka A, et al. Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol (1985). 1997 Apr;82(4):1319-26.[Abstract][Full Text]
23. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal EMG in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest. 1992 May;89(5):1571-9. [Abstract][Full Text]
24. Lal C, Ayappa I, Ayas N, et al. The link between obstructive sleep apnea and neurocognitive impairment: an official American Thoracic Society Workshop report. Ann Am Thorac Soc. 2022 Aug;19(8):1245-56.[Abstract][Full Text]
25. Mehra R, Chung MK, Olshansky B, et al. Sleep-disordered breathing and cardiac arrhythmias in adults: mechanistic insights and clinical implications: a scientific statement from the American Heart Association. Circulation. 2022 Aug 30;146(9):e119-e136.[Abstract][Full Text]
26. Bonsignore MR, Randerath W, Schiza S, et al. European Respiratory Society statement on sleep apnoea, sleepiness and driving risk. Eur Respir J. 2021 Feb;57(2):2001272.[Abstract][Full Text]
27. Das AM, Chang JL, Berneking M, et al. Enhancing public health and safety by diagnosing and treating obstructive sleep apnea in the transportation industry: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2022 Oct 1;18(10):2467-70.[Abstract][Full Text]
28. Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis. 2015 Aug;7(8):1311-22.[Abstract][Full Text]
29. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000 Dec 20;284(23):3015-21. [Abstract][Full Text]
30. Tishler PV, Larkin EK, Schluchter MD, et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA. 2003 May 7;289(17):2230-7.[Abstract][Full Text]
31. Thompson C, Legault J, Moullec G, et al. A portrait of obstructive sleep apnea risk factors in 27,210 middle-aged and older adults in the Canadian Longitudinal Study on Aging. Sci Rep. 2022 Mar 24;12(1):5127.[Abstract][Full Text]
32. Young T, Finn L, Austin D, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med. 2003 May 1;167(9):1181-5.[Abstract][Full Text]
33. Huang T, Lin BM, Redline S, et al. Type of menopause, age at menopause, and risk of developing obstructive sleep apnea in postmenopausal women. Am J Epidemiol. 2018 Jul 1;187(7):1370-9.[Abstract][Full Text]
34. Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med. 1997 Oct 15;127(8 Pt 1):581-7.[Abstract]
35. Tsuiki S, Isono S, Ishikawa T, et al. Anatomical balance of the upper airway and obstructive sleep apnea. Anesthesiology. 2008 Jun;108(6):1009-15.[Abstract][Full Text]
36. Friedman M, Ibrahim H, Bass L. Clinical staging for sleep-disordered breathing. Otolaryngol Head Neck Surg. 2002 Jul;127(1):13-21.[Abstract]
37. Pillar G, Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):688-91.[Abstract]
38. Deegan PC, McNicholas WT. Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J. 1996 Jan;9(1):117-24.[Abstract][Full Text]
39. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017 Mar 15;13(3):479-504.[Abstract][Full Text]
40. Kahal H, Kyrou I, Uthman OA, et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath. 2020 Mar;24(1):339-50.[Abstract][Full Text]
41. Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab. 2001 Feb;86(2):517-20.[Abstract][Full Text]
42. Fernandez RC, Moore VM, Van Ryswyk EM, et al. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nat Sci Sleep. 2018;10:45-64.[Abstract][Full Text]
43. Rajagopal KR, Abbrecht PH, Derderian SS, et al. Obstructive sleep apnea in hypothyroidism. Ann Intern Med. 1984 Oct;101(4):491-4.[Abstract]
44. Lee CF, Lee CH, Hsueh WY, et al. Prevalence of obstructive sleep apnea in children with Down syndrome: a meta-analysis. J Clin Sleep Med. 2018 May 15;14(5):867-75.[Abstract][Full Text]
45. de Miguel-Diez J, Villa-Asensi JR, Alvarez-Sala JL. Prevalence of sleep-disordered breathing in children with Down syndrome: polygraphic findings in 108 children. Sleep. 2003 Dec 15;26(8):1006-9. [Abstract][Full Text]
46. Lin HY, Chen MR, Lin CC, et al. Polysomnographic characteristics in patients with mucopolysaccharidoses. Pediatr Pulmonol. 2010 Dec;45(12):1205-12.[Abstract]
47. Moreira GA, Kyosen SO, Patti CL, et al. Prevalence of obstructive sleep apnea in patients with mucopolysaccharidosis types I, II, and VI in a reference center. Sleep Breath. 2014 Dec;18(4):791-7.[Abstract]
48. Zeng X, Ren Y, Wu K, et al. Association between smoking behavior and obstructive sleep apnea: a systematic review and meta-analysis. Nicotine Tob Res. 2023 Feb 9;25(3):364-7.[Abstract][Full Text]
49. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol. 1997 Feb;99(2):S757-62.[Abstract][Full Text]
50. Young T, Finn L, Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med. 2001 Jun 25;161(12):1514-9.[Abstract][Full Text]
51. Payne K, Lipshultz LI, Hotaling JM, et al. Obstructive sleep apnea and testosterone therapy. Sex Med Rev. 2021 Apr;9(2):296-303.[Abstract]
52. Cole AP, Hanske J, Jiang W, et al. Impact of testosterone replacement therapy on thromboembolism, heart disease and obstructive sleep apnoea in men. BJU Int. 2018 May;121(5):811-8.[Abstract][Full Text]
53. Kolla BP, Foroughi M, Saeidifard F, et al. The impact of alcohol on breathing parameters during sleep: A systematic review and meta-analysis. Sleep Med Rev. 2018 Dec;42:59-67.[Abstract][Full Text]
54. Chang CW, Chang CH, Chuang HY, et al. What is the association between secondhand smoke (SHS) and possible obstructive sleep apnea: a meta-analysis. Environ Health. 2022 Jun 16;21(1):58.[Abstract][Full Text]
55. Rosen IM, Aurora RN, Kirsch DB, et al. Chronic opioid therapy and sleep: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2019 Nov 15;15(11):1671-3.[Abstract][Full Text]
56. Mason M, Cates CJ, Smith I. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011090.[Abstract][Full Text]
57. Eckert DJ, White DP, Jordan AS, et al. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med. 2013 Oct 15;188(8):996-1004.[Abstract][Full Text]
58. Pien GW, Ye L, Keenan BT, et al. Changing faces of obstructive sleep apnea: treatment effects by cluster designation in the Icelandic sleep apnea cohort. Sleep. 2018 Mar 1;41(3):zsx201.[Abstract][Full Text]
59. Lin CM, Davidson TM, Ancoli-Israel S. Gender differences in obstructive sleep apnea and treatment implications. Sleep Med Rev. 2008 Dec;12(6):481-96.[Abstract][Full Text]
60. Lozo T, Komnenov D, Badr MS, et al. Sex differences in sleep disordered breathing in adults. Respir Physiol Neurobiol. 2017 Nov;245:65-75.[Abstract]
61. Guilleminault C, Bassiri A. Clinical features and evaluation of obstructive sleep apnea. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:1043-52.
62. Kezirian EJ, Harrison SL, Ancoli-Israel S, et al; Study of Osteoporotic Fractures in Men Research Group. Behavioral correlates of sleep-disordered breathing in older men. Sleep. 2009 Feb;32(2):253-61.[Abstract][Full Text]
63. Bucks RS, Olaithe M, Eastwood P. Neurocognitive function in obstructive sleep apnoea: a meta-review. Respirology. 2013 Jan;18(1):61-70.[Abstract][Full Text]
64. Barbosa FT, Silva MP, Fontes LES, et al. Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea. Cochrane Database Syst Rev. 2021 Sep 23;9(9):CD013169.[Abstract][Full Text]
65. Ng JH, Song YL, Yap AUJ. Effects of bicuspid extractions and incisor retraction on upper airway of Asian adults and late adolescents: a systematic review. J Oral Rehabil. 2019 Nov;46(11):1071-87.[Abstract][Full Text]
66. Epstein LJ, Kristo D, Strollo PJ Jr, et al; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009 Jun 15;5(3):263-76.[Abstract][Full Text]
67. Medicare. Coverage issues manual 10-15-2008: transmittal 96. 2008 [internet publication].[Full Text]
68. American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events. Feb 2023 [internet publication].[Full Text]
69. Kuna ST, Gurubhagavatula I, Maislin G, et al. Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea. Am J Respir Crit Care Med. 2011 May 1;183(9):1238-44.[Abstract][Full Text]
70. Patil SP, Ayappa IA, Caples SM, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine clinical practice guideline. Sleep. 2019 Feb 15;15(2):335-43. [Abstract][Full Text]
71. Iber C, Ancoli-Israel S, Chesson A, et al; American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine; 2007.
72. Masa JF, Corral J, Pereira R, et al. Effectiveness of home respiratory polygraphy for the diagnosis of sleep apnoea and hypopnoea syndrome. Thorax. 2011 Jul;66(7):567-73.[Abstract][Full Text]
73. Masa JF, Corral J, Pereira R, et al. Therapeutic decision-making for sleep apnea and hypopnea syndrome using home respiratory polygraphy: a large multicentric study. Am J Respir Crit Care Med. 2011 Oct 15;184(8):964-71.[Abstract][Full Text]
74. El Shayeb M, Topfer LA, Stafinski T, et al. Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis. CMAJ. 2014 Jan 7;186(1):E25-51. [Abstract][Full Text]
75. Rosen CL, Auckley D, Benca R, et al. A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and treatment of obstructive sleep apnea: the HomePAP study. Sleep. 2012 Jun 1;35(6):757-67.[Abstract][Full Text]
76. Ghegan MD, Angelos PC, Stonebraker AC, et al. Laboratory versus portable sleep studies: a meta-analysis. Laryngoscope. 2006 Jun;116(6):859-64.[Abstract]
77. Rosen IM, Kirsch DB, Carden KA, et al. Clinical use of a home sleep apnea test: an updated American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2018 Dec 15;14(12):2075-7.[Abstract][Full Text]
78. Zou D, Grote L, Peker Y, et al. Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography. Sleep. 2006 Mar;29(3):367-74. [Abstract][Full Text]
79. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021 Jul 20;144(3):e56-67.[Abstract][Full Text]
80. Yu Z, Cheng JX, Zhang D, et al. Association between obstructive sleep apnea and Type 2 diabetes mellitus: a dose-response meta-analysis. Evid Based Complement Alternat Med. 2021;2021:1337118.[Abstract][Full Text]
81. Parolin M, Dassie F, Alessio L, et al. Obstructive sleep apnea in acromegaly and the effect of treatment: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz116.[Abstract][Full Text]
82. El Hage Chehade N, Fu Y, Ghoneim S, et al. Association between obstructive sleep apnea and gastroesophageal reflux disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2023 Aug;38(8):1244-51.[Abstract][Full Text]
83. Wu ZH, Yang XP, Niu X, et al. The relationship between obstructive sleep apnea hypopnea syndrome and gastroesophageal reflux disease: a meta-analysis. Sleep Breath. 2019 Jun;23(2):389-97.[Abstract][Full Text]
84. Zhou J, Xia S, Li T, et al. Association between obstructive sleep apnea syndrome and nocturia: a meta-analysis. Sleep Breath. 2020 Dec;24(4):1293-8.[Abstract]
85. Nguyen-Hoang Y, Nguyen-Thi-Dieu T, Duong-Quy S. Study of the clinical and functional characteristics of asthmatic children with obstructive sleep apnea. J Asthma Allergy. 2017;10:285-92.[Abstract][Full Text]
86. Chan AS, Lee RW, Srinivasan VK, et al. Nasopharyngoscopic evaluation of oral appliance therapy for obstructive sleep apnoea. Eur Respir J. 2010 Apr;35(4):836-42.[Abstract][Full Text]
87. Volner K, Chao S, Camacho M. Dynamic sleep MRI in obstructive sleep apnea: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2022 Feb;279(2):595-607.[Abstract][Full Text]
88. Pépin JL, Letesson C, Le-Dong NN, et al. Assessment of mandibular movement monitoring with machine learning analysis for the diagnosis of obstructive sleep apnea. JAMA Netw Open. 2020 Jan 3;3(1):e1919657.[Abstract][Full Text]
89. Raphelson JR, Ahmed IM, Ancoli-Israel S, et al. Evaluation of a novel device to assess obstructive sleep apnea and body position. J Clin Sleep Med. 2023 Sep 1;19(9):1643-9.[Abstract]
90. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991 Dec;14(6):540-5. [Abstract][Full Text]
91. Schiza SE, Bouloukaki I. Screening for obstructive sleep apnoea in professional drivers. Breathe (Sheff). 2020 Mar;16(1):29364.[Abstract][Full Text]
92. US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. JAMA. 2022 Nov 15;328(19):1945-50.[Abstract][Full Text]
93. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008 May;108(5):812-21. [Abstract][Full Text]
94. Patel D, Tsang J, Saripella A, et al. Validation of the STOP questionnaire as a screening tool for OSA among different populations: a systematic review and meta-regression analysis. J Clin Sleep Med. 2022 May 1;18(5):1441-53.[Abstract][Full Text]
95. Chen L, Pivetta B, Nagappa M, et al. Validation of the STOP-Bang questionnaire for screening of obstructive sleep apnea in the general population and commercial drivers: a systematic review and meta-analysis. Sleep Breath. 2021 Dec;25(4):1741-51.[Abstract][Full Text]
96. Hwang M, Nagappa M, Guluzade N, et al. Validation of the STOP-Bang questionnaire as a preoperative screening tool for obstructive sleep apnea: a systematic review and meta-analysis. BMC Anesthesiol. 2022 Nov 30;22(1):366.[Abstract][Full Text]
97. Hwang M, Zhang K, Nagappa M, et al. Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnoea in patients with cardiovascular risk factors: a systematic review and meta-analysis. BMJ Open Respir Res. 2021 Mar;8(1):e000848.[Abstract][Full Text]
98. Chiu HY, Chen PY, Chuang LP, et al. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev. 2017 Dec;36:57-70.[Abstract]
99. Krahn LE, Arand DL, Avidan AY, et al. Recommended protocols for the multiple sleep latency test and maintenance of wakefulness test in adults: guidance from the American Academy of Sleep Medicine. J Clin Sleep Med. 2021 Dec 1;17(12):2489-98.[Abstract][Full Text]
100. Mysliwiec V, Martin JL, Ulmer CS, et al. The management of chronic insomnia disorder and obstructive sleep apnea: synopsis of the 2019 US Department of Veterans Affairs and US Department of Defense clinical practice guidelines. Ann Intern Med. 2020 Mar 3;172(5):325-36.[Abstract][Full Text]
101. Smith MT, McCrae CS, Cheung J, et al. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2018 Jul 15;14(7):1231-7. [Abstract][Full Text]
102. National Institute for Health and Care Excellence. Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s. Aug 2021 [internet publication].[Full Text]
103. Gao W, Jin Y, Wang Y, et al. Is automatic CPAP titration as effective as manual CPAP titration in OSAHS patients? A meta-analysis. Sleep Breath. 2012 Jun;16(2):329-40.[Abstract]
104. McDaid C, Durée KH, Griffin SC, et al. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev. 2009 Dec;13(6):427-36.[Abstract]
105. Kushida CA, Nichols DA, Holmes TH, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep. 2012 Dec 1;35(12):1593-602. [Abstract][Full Text]
106. Martínez-García MÁ, Chiner E, Hernández L, et al; Spanish Sleep Network. Obstructive sleep apnoea in the elderly: role of continuous positive airway pressure treatment. Eur Respir J. 2015 Jul;46(1):142-51.[Abstract][Full Text]
107. McMillan A, Bratton DJ, Faria R, et al. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT. Health Technol Assess. 2015 Jun;19(40):1-188.[Abstract][Full Text]
108. Dalmases M, Solé-Padullés C, Torres M, et al. Effect of CPAP on cognition, brain function, and structure among elderly patients with OSA: a randomized pilot study. Chest. 2015 Nov;148(5):1214-23.[Abstract]
109. Zheng D, Xu Y, You S, et al. Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the sleep apnoea cardiovascular Endpoint randomised trial and meta-analysis. EClinicalMedicine. 2019 May-Jun;11:89-96.[Abstract][Full Text]
110. Khan SU, Duran CA, Rahman H, et al. A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea. Eur Heart J. 2018 Jun 21;39(24):2291-7.[Abstract][Full Text]
111. Antonopoulos CN, Sergentanis TN, Daskalopoulou SS, et al. Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: a meta-analysis. Sleep Med Rev. 2011 Oct;15(5):301-10. [Abstract]
112. Fava C, Dorigoni S, Dalle Vedove F, et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest. 2014 Apr;145(4):762-71.[Abstract]
113. Labarca G, Schmidt A, Dreyse J, et al. Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): systematic review and meta-analysis. Sleep Med Rev. 2021 Aug;58:101446.[Abstract]
114. Shang W, Zhang Y, Liu L, et al. Benefits of continuous positive airway pressure on blood pressure in patients with hypertension and obstructive sleep apnea: a meta-analysis. Hypertens Res. 2022 Nov;45(11):1802-1813.[Abstract]
115. Bratton DJ, Stradling JR, Barbé F, et al. Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials. Thorax. 2014 Dec;69(12):1128-35.[Abstract][Full Text]
116. Affas Z, Affas S, Tabbaa K. Continuous positive airway pressure reduces the incidence of atrial fibrillation in patients with obstructive sleep apnea: a meta-analysis and systematic review. Spartan Med Res J. 2022;7(2):34521.[Abstract][Full Text]
117. Deng F, Raza A, Guo J. Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a meta-analysis. Sleep Med. 2018 Jun;46:5-11.[Abstract]
118. Yang Y, Ning Y, Wen W, et al. CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis. J Interv Card Electrophysiol. 2020 Sep;58(3):369-79.[Abstract]
119. Shukla A, Aizer A, Holmes D, et al. Effect of obstructive sleep apnea treatment on atrial fibrillation recurrence: a meta-analysis. JACC Clin Electrophysiol. 2015 Mar-Apr;1(1-2):41-51.[Abstract]
120. Sánchez-de-la-Torre M, Sánchez-de-la-Torre A, Bertran S, et al. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med. 2020 Apr;8(4):359-67.[Abstract]
121. Labarca G, Dreyse J, Drake L, et al. Efficacy of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea: systematic review and meta-analysis. Sleep Med Rev. 2020 Aug;52:101312.[Abstract]
122. Yu J, Zhou Z, McEvoy RD, et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA. 2017 Jul 11;318(2):156-66.[Abstract][Full Text]
123. Drager LF, Brunoni AR, Jenner R, et al. Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials. Thorax. 2015 Mar;70(3):258-64. [Abstract][Full Text]
124. Labarca G, Reyes T, Jorquera J, et al. CPAP in patients with obstructive sleep apnea and type 2 diabetes mellitus: systematic review and meta-analysis. Clin Respir J. 2018 Aug;12(8):2361-8.[Abstract]
125. Zhu B, Ma C, Chaiard J, et al. Effect of continuous positive airway pressure on glucose metabolism in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Sleep Breath. 2018 May;22(2):287-95.[Abstract]
126. Weaver TE, Mancini C, Maislin G, et al. Continuous positive airway pressure treatment of sleepy patients with milder obstructive sleep apnea: results of the CPAP Apnea Trial North American Program (CATNAP) randomized clinical trial. Am J Respir Crit Care Med. 2012 Oct 1;186(7):677-83.[Abstract][Full Text]
127. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993 Apr;147(4):887-95. [Abstract]
128. Donovan LM, Hoyos CM, Kimoff RJ, et al. Strategies to assess the effect of continuous positive airway pressure on long-term clinically important outcomes among patients with symptomatic obstructive sleep apnea: an official American Thoracic Society Workshop report. Ann Am Thorac Soc. 2023 Jul;20(7):931-43.[Abstract][Full Text]
129. Agency for Healthcare Research and Quality. Long-term health outcomes in obstructive sleep apnea: a systematic review of comparative studies evaluating positive airway pressure and the validity of breathing measures as surrogate outcomes. Dec 2022 [internet publication].[Full Text]
130. Bachour A, Maasilta P. Mouth breathing compromises adherence to nasal continuous positive airway pressure therapy. Chest. 2004 Oct;126(4):1248-54.[Abstract]
131. Bachour A, Hurmerinta K, Maasilta P. Mouth closing device (chinstrap) reduces mouth leak during nasal CPAP. Sleep Med. 2004 May;5(3):261-7.[Abstract]
132. Askland K, Wright L, Wozniak DR, et al. Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2020 Apr 7;4(4):CD007736.[Abstract][Full Text]
133. Labarca G, Schmidt A, Dreyse J, et al. Telemedicine interventions for CPAP adherence in obstructive sleep apnea patients: systematic review and meta-analysis. Sleep Med Rev. 2021 Dec;60:101543.[Abstract]
134. Nakata S, Noda A, Yagi H, et al. Nasal resistance for determinant factor of nasal surgery in CPAP failure patients with obstructive sleep apnea syndrome. Rhinology. 2005 Dec;43(4):296-9.[Abstract]
135. Sugiura T, Noda A, Nakata S, et al. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration. 2007;74(1):56-60. [Abstract]
136. Friedman M, Tanyeri H, Lim JW, et al. Effect of improved nasal breathing on obstructive sleep apnea. Otolaryngol Head Neck Surg. 2000 Jan;122(1):71-4. [Abstract]
137. Poirier J, George C, Rotenberg B. The effect of nasal surgery on nasal continuous positive airway pressure compliance. Laryngoscope. 2014 Jan;124(1):317-9.[Abstract]
138. Park CY, Hong JH, Lee JH, et al. Clinical effect of surgical correction for nasal pathology on the treatment of obstructive sleep apnea syndrome. PLoS One. 2014;9(6):e98765.[Abstract][Full Text]
139. Morgenthaler TI, Kapen S, Lee-Chiong T, et al. Standards of Practice Committee; American Academy of Sleep Medicine. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006 Aug;29(8):1031-5.[Abstract]
140. Lettieri CJ, Quast TN, Eliasson AH, et al. Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial. Sleep. 2008 Sep;31(9):1310-6.[Abstract][Full Text]
141. Ip S, D'Ambrosio C, Patel K, et al. Auto-titrating versus fixed continuous positive airway pressure for the treatment of obstructive sleep apnea: a systematic review with meta-analyses. Syst Rev. 2012 Mar 8;1:20.[Abstract][Full Text]
142. Kennedy B, Lasserson TJ, Wozniak DR, et al. Pressure modification or humidification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD003531. [Abstract][Full Text]
143. Boyer L, Philippe C, Covali-Noroc A, et al. OSA treatment with CPAP: randomized crossover study comparing tolerance and efficacy with and without humidification by ThermoSmart. Clin Respir J. 2019 Jun;13(6):384-90.[Abstract]
144. Wiest GH, Harsch IA, Fuchs FS, et al. Initiation of CPAP therapy for OSA: does prophylactic humidification during CPAP pressure titration improve initial patient acceptance and comfort? Respiration. 2002;69(5):406-12.[Abstract]
145. Bakker JP, Marshall NS. Flexible pressure delivery modification of continuous positive airway pressure for obstructive sleep apnea does not improve compliance with therapy: systematic review and meta-analysis. Chest. 2011 Jun;139(6):1322-30. [Abstract]
146. Killick R, Marshall NS. The impact of device modifications and pressure delivery on adherence. Sleep Med Clin. 2021 Mar;16(1):75-84.[Abstract]
147. Tsuda H, Almeida FR, Tsuda T, et al. Craniofacial changes after 2 years of nasal continuous positive airway pressure use in patients with obstructive sleep apnea. Chest. 2010 Oct;138(4):870-4. [Abstract]
148. Pépin JL, Leger P, Veale D, et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest. 1995 Feb;107(2):375-81.[Abstract]
149. Ramar K, Dort LC, Katz SG, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015 Jul 15;11(7):773-827. [Abstract][Full Text]
150. Ferguson KA, Cartwright R, Rogers R, et al. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep. 2006 Feb;29(2):244-62.[Abstract][Full Text]
151. Doff MH, Hoekema A, Wijkstra PJ, et al. Oral appliance versus continuous positive airway pressure in obstructive sleep apnea syndrome: a 2-year follow-up. Sleep. 2013 Sep 1;36(9):1289-96. [Abstract][Full Text]
152. Holley AB, Lettieri CJ, Shah AA. Efficacy of an adjustable oral appliance and comparison with continuous positive airway pressure for the treatment of obstructive sleep apnea syndrome. Chest. 2011 Dec;140(6):1511-6. [Abstract]
153. Povitz M, Bolo CE, Heitman SJ, et al. Effect of treatment of obstructive sleep apnea on depressive symptoms: systematic review and meta-analysis. PLoS Med. 2014 Nov 25;11(11):e1001762.[Abstract][Full Text]
154. Randerath WJ, Heise M, Hinz R, et al. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest. 2002 Aug;122(2):569-75. [Abstract]
155. Vena D, Azarbarzin A, Marques M, et al. Predicting sleep apnea responses to oral appliance therapy using polysomnographic airflow. Sleep. 2020 Jul 13;43(7):zsaa004.[Abstract]
156. Johal A, Hector MP, Battagel JM, et al. Impact of sleep nasendoscopy on the outcome of mandibular advancement splint therapy in subjects with sleep-related breathing disorders. J Laryngol Otol. 2007 Jul;121(7):668-75.[Abstract]
157. Hoffstein V. Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath. 2007 Mar;11(1):1-22.[Abstract][Full Text]
158. Chang ET, Fernandez-Salvador C, Giambo J, et al. Tongue retaining devices for obstructive sleep apnea: a systematic review and meta-analysis. Am J Otolaryngol. 2017 May-Jun;38(3):272-8.[Abstract]
159. Vanderveken OM, Dieltjens M, Wouters K, et al. Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing. Thorax. 2013 Jan;68(1):91-6. [Abstract][Full Text]
160. Cahali MB, Formigoni GG, Gebrim EM, et al. Lateral pharyngoplasty versus uvulopalatopharyngoplasty: a clinical, polysomnographic and computed tomography measurement comparison. Sleep. 2004 Aug 1;27(5):942-50. [Abstract][Full Text]
161. Woodson BT, Robinson S, Lim HJ. Transpalatal advancement pharyngoplasty outcomes compared with uvulopalatopharygoplasty. Otolaryngol Head Neck Surg. 2005 Aug;133(2):211-7.[Abstract]
162. Pang KP, Woodson BT. Expansion sphincter pharyngoplasty: a new technique for the treatment of obstructive sleep apnea. Otolaryngol Head Neck Surg. 2007 Jul;137(1):110-4.[Abstract]
163. Iannella G, Lechien JR, Perrone T, et al. Barbed reposition pharyngoplasty (BRP) in obstructive sleep apnea treatment: state of the art. Am J Otolaryngol. 2022 Jan-Feb;43(1):103197.[Abstract]
164. Riley RW, Powell NB, Guilleminault C. Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients. Otolaryngol Head Neck Surg. 1993 Feb;108(2):117-25.[Abstract]
165. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002 Jul 15;166(2):159-65.[Abstract][Full Text]
166. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006 Sep;28(3):596-602.[Abstract][Full Text]
167. Keenan SP, Burt H, Ryan CF, et al. Long-term survival of patients with obstructive sleep apnea treated by uvulopalatopharyngoplasty or nasal CPAP. Chest. 1994 Jan;105(1):155-9. [Abstract]
168. Marti S, Sampol G, Munoz X, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J. 2002 Dec;20(6):1511-8.[Abstract][Full Text]
169. Weaver EM, Maynard C, Yueh B. Survival of veterans with sleep apnea: continuous positive airway pressure versus surgery. Otolaryngol Head Neck Surg. 2004 Jun;130(6):659-65. [Erratum in: Otolaryngol Head Neck Surg. 2004 Jul;131(1):144.][Abstract]
170. Woodson BT, Steward DL, Weaver EM, et al. A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg. 2003 Jun;128(6):848-61.[Abstract]
171. Browaldh N, Bring J, Friberg D. SKUP(3) RCT; continuous study: changes in sleepiness and quality of life after modified UPPP. Laryngoscope. 2016 Jun;126(6):1484-91.[Abstract]
172. Ishman SL, Benke JR, Cohen AP, et al. Does surgery for obstructive sleep apnea improve depression and sleepiness? Laryngoscope. 2014 Dec;124(12):2829-36.[Abstract][Full Text]
173. MacKay S, Carney AS, Catcheside PG, et al. Effect of multilevel upper airway surgery vs medical management on the Apnea-Hypopnea Index and patient-reported daytime sleepiness among patients with moderate or severe obstructive sleep apnea: the SAMS randomized clinical trial. JAMA. 2020 Sep 4 [Epub ahead of print].[Abstract][Full Text]
174. Lin HC, Friedman M, Chang HW, et al. The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea/hypopnea syndrome. Laryngoscope. 2008 May;118(5):902-8.[Abstract]
175. Caples SM, Rowley JA, Prinsell JR, et al. Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep. 2010 Oct;33(10):1396-407.[Abstract][Full Text]
176. Browaldh N, Nerfeldt P, Lysdahl M, et al. SKUP3 randomised controlled trial: polysomnographic results after uvulopalatopharyngoplasty in selected patients with obstructive sleep apnoea. Thorax. 2013 Sep;68(9):846-53.[Abstract][Full Text]
177. Kent D, Stanley J, Aurora RN, et al. Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021 Dec 1;17(12):2507-31.[Abstract][Full Text]
178. Holty JE, Guilleminault C. Maxillomandibular advancement for the treatment of obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev. 2010 Oct;14(5):287-97.[Abstract]
179. Li HY, Wang PC, Chen YP, et al. Critical appraisal and meta-analysis of nasal surgery for obstructive sleep apnea. Am J Rhinol Allergy. Jan-Feb 2011;25(1):45-9.[Abstract]
180. Ishii L, Roxbury C, Godoy A, et al. Does nasal surgery improve OSA in patients with nasal obstruction and OSA? A meta-analysis. Otolaryngol Head Neck Surg. 2015 Sep;153(3):326-33.[Abstract]
181. Li HY, Wang PC, Lee LA, et al. Prediction of uvulopalatopharyngoplasty outcome: anatomy-based staging system versus severity-based staging system. Sleep. 2006 Dec;29(12):1537-41. [Abstract][Full Text]
182. Senior BA, Rosenthal L, Lumley A, et al. Efficacy of uvulopalatopharyngoplasty in unselected patients with mild obstructive sleep apnea. Otolaryngol Head Neck Surg. 2000 Sep;123(3):179-82.[Abstract]
183. Friedman M, Vidyasagar R, Bliznikas D, et al. Does severity of obstructive sleep apnea/hypopnea syndrome predict uvulopalatopharyngoplasty outcome? Laryngoscope. 2005 Dec;115(12):2109-13.[Abstract]
184. Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014 Jan 9;370(2):139-49.[Abstract][Full Text]
185. Lee CH, Seay EG, Walters BK, et al. Therapeutic positive airway pressure level predicts response to hypoglossal nerve stimulation for obstructive sleep apnea. J Clin Sleep Med. 2019 Aug 15;15(8):1165-72.[Abstract][Full Text]
186. Kent DT, Carden KA, Wang L, et al. Evaluation of hypoglossal nerve stimulation treatment in obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg. 2019 Nov 1;145(11):1044-52.[Abstract][Full Text]
187. Bosschieter PFN, de Vries N, Mehra R, et al. Similar effect of hypoglossal nerve stimulation for obstructive sleep apnea in 5 disease severity categories. J Clin Sleep Med. 2022 Jun 1;18(6):1657-65.[Abstract][Full Text]
188. Huntley C, Kaffenberger T, Doghramji K, et al. Upper airway stimulation for treatment of obstructive sleep apnea: an evaluation and comparison of outcomes at two academic centers. J Clin Sleep Med. 2017 Sep 15;13(9):1075-9.[Abstract][Full Text]
189. Dedhia RC, Woodson BT. Standardized reporting for hypoglossal nerve stimulation outcomes. J Clin Sleep Med. 2018 Nov 15;14(11):1835-6.[Abstract][Full Text]
190. Roth T, Rippon GA, Arora S. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea. Sleep Breath. 2008 Mar;12(1):53-62. [Abstract][Full Text]
191. Lehert P. Efficacy of pitolisant 20 mg in reducing excessive daytime sleepiness and fatigue in patients with obstructive sleep apnoea syndrome: an individual patient data meta-analysis. Clin Drug Investig. 2022 Jan;42(1):65-74.[Abstract][Full Text]
192. Pépin JL, Georgiev O, Tiholov R, et al. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial. Chest. 2021 Apr;159(4):1598-609.[Abstract][Full Text]
193. Wang J, Li X, Yang S, et al. Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a meta-analysis from randomized controlled trials. Pharmacol Res. 2021 May;167:105522.[Abstract]
194. Abad VC, Guilleminault C. Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea. Expert Rev Respir Med. 2018 Dec;12(12):1007-19.[Abstract]
195. Cuomo MC, Sheehan AH, Jordan JK. Solriamfetol for the management of excessive daytime sleepiness. J Pharm Pract. 2022 Dec;35(6):963-70.[Abstract]
196. Malhotra A, Shapiro C, Pepin JL, et al. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea. Sleep. 2020 Feb 13;43(2):zsz220.[Abstract][Full Text]
197. National Institute for Health and Care Excellence. Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea. Mar 2022 [internet publication].[Full Text]
198. National Institute for Health and Care Excellence. Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea. Mar 2022 [internet publication].[Full Text]
199. Carneiro-Barrera A, Díaz-Román A, Guillén-Riquelme A, et al. Weight loss and lifestyle interventions for obstructive sleep apnoea in adults: systematic review and meta-analysis. Obes Rev. 2019 May;20(5):750-62.[Abstract]
200. Mitchell LJ, Davidson ZE, Bonham M, et al. Weight loss from lifestyle interventions and severity of sleep apnoea: a systematic review and meta-analysis. Sleep Med. 2014 Oct;15(10):1173-83.[Abstract]
201. Ng WL, Stevenson CE, Wong E, et al. Does intentional weight loss improve daytime sleepiness? A systematic review and meta-analysis. Obes Rev. 2017 Apr;18(4):460-75.[Abstract]
202. Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med. 1985 Dec;103(6 [Pt 1]):850-5.[Abstract]
203. Schwartz AR, Gold AR, Schubert N, et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):494-8. [Abstract]
204. Valencia-Flores M, Orea A, Herrera M, et al. Effect of bariatric surgery on obstructive sleep apnea and hypopnea syndrome, electrocardiogram, and pulmonary arterial pressure. Obes Surg. Jun-Jul 2004;14(6):755-62. [Abstract]
205. Ashrafian H, Toma T, Rowland SP, et al. Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg. 2015 Jul;25(7):1239-50.[Abstract]
206. Wong AM, Barnes HN, Joosten SA, et al. The effect of surgical weight loss on obstructive sleep apnoea: a systematic review and meta-analysis. Sleep Med Rev. 2018 Dec;42:85-99.[Abstract]
207. Srijithesh PR, Aghoram R, Goel A, et al. Positional therapy for obstructive sleep apnoea. Cochrane Database Syst Rev. 2019 May 1;(5):CD010990.[Abstract][Full Text]
208. Schweitzer PK, Maynard JP, Wylie PE, et al. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility. Sleep Breath. 2023 May;27(2):495-503.[Abstract][Full Text]
209. Taranto-Montemurro L, Messineo L, Sands SA, et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med. 2019 May 15;199(10):1267-76.[Abstract][Full Text]
210. Schweitzer PK, Taranto-Montemurro L, Ojile JM, et al. The combination of aroxybutynin and atomoxetine in the treatment of obstructive sleep apnea (MARIPOSA): a randomized controlled trial. Am J Respir Crit Care Med. 9 Oct 2023 [Epub ahead of print].[Abstract][Full Text]
211. Rosenberg R, Abaluck B, Thein S. Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA. J Clin Sleep Med. 2022 Dec 1;18(12):2837-44.[Abstract]
212. Schwartz AR, Jacobowitz O, Eisele DW, et al. Targeted hypoglossal nerve stimulation for patients with obstructive sleep apnea: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2023 Jun 1;149(6):512-20.[Abstract][Full Text]
213. Eastwood PR, Barnes M, MacKay SG, et al. Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnoea. Eur Respir J. 2020 Jan 9;55(1):1901320.[Abstract][Full Text]
214. ClinicalTrials.gov. Safety and effectiveness of the Genio® bilAteral Stimulation for treatment of Complete Concentric CollapsE and OSA. (ACCCESS). ClinicalTrials.gov Identifier: NCT05592002. Feb 2023 [internet publication].[Full Text]
215. ClinicalTrials.gov. Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM) (DREAM). ClinicalTrials.gov Identifier: NCT03868618. 19 Apr 2023 [internet publication].[Full Text]
216. Kent DT, Zealear D, Schwartz AR. Ansa cervicalis stimulation: a new direction in neurostimulation for OSA. Chest. 2021 Mar;159(3):1212-21.[Abstract][Full Text]
217. ClinicalTrials.gov. Ansa cervicalis and hypoglossal nerve stimulation in OSA. ClinicalTrials.gov Identifier: NCT05501236. Aug 2022 [internet publication].[Full Text]
218. Blackman A, Foster GD, Zammit G, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016 Aug;40(8):1310-9.[Abstract][Full Text]
219. ClinicalTrials.gov. Effect of liraglutide vs CPAP on cardiometabolic outcomes in obstructive sleep apnea. ClinicalTrials.gov Identifier: NCT04186494. 31Jan 2022 [internet publication].[Full Text]
220. Hudgel DW, Patel SR, Ahasic AM, et al. The role of weight management in the treatment of adult obstructive sleep apnea. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2018 Sep 15;198(6):e70-87.[Abstract][Full Text]
221. American Society of Anesthesiologists. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists task force on perioperative management of patients with obstructive sleep apnea. Anesthesiology. 2014 Feb;120(2):268-86.[Abstract][Full Text]
222. Lisan Q, Van Sloten T, Marques Vidal P, et al. Association of positive airway pressure prescription with mortality in patients with obesity and severe obstructive sleep apnea: the Sleep Heart Health Study. JAMA Otolaryngol Head Neck Surg. 2019 Jun 1;145(6):509-15.[Abstract][Full Text]
223. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005 Mar 19-25;365(9464):1046-53.[Abstract]
224. Molnar MZ, Mucsi I, Novak M, et al. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax. 2015 Sep;70(9):888-95. [Abstract][Full Text]
225. Bassetti CLA, Randerath W, Vignatelli L, et al. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. Eur J Neurol. 2020 Jul;27(7):1117-36.[Abstract][Full Text]
226. Gottesman RF, Lutsey PL, Benveniste H, et al. Impact of sleep disorders and disturbed sleep on brain health: a scientific statement from the American Heart Association. Stroke. 2024 Mar;55(3):e61-76.[Abstract][Full Text]
227. Banno K, Kryger MH. Sleep apnea: clinical investigations in humans. Sleep Med. 2007 Jun;8(4):400-26.[Abstract]
228. Naegele B, Thouvard V, Pepin JL, et al. Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep. 1995 Jan;18(1):43-52.[Abstract]
229. Guay-Gagnon M, Vat S, Forget MF, et al. Sleep apnea and the risk of dementia: a systematic review and meta-analysis. J Sleep Res. 2022 Oct;31(5):e13589.[Abstract]
230. Zimmerman ME, Aloia MS. A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med. 2006 Oct 15;2(4):461-71.[Abstract]
231. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med. 2003 Jul;254(1):32-44.[Abstract][Full Text]
232. Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008 Aug;31(8):1079-85.[Abstract][Full Text]
233. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin Sleep Cohort. Sleep. 2008 Aug;31(8):1071-8.[Abstract][Full Text]
234. Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N, et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest. 2005 Aug;128(2):624-33.[Abstract]
235. Kushida CA, Littner MR, Morgenthaler T, et al; American Academy of Sleep Medicine. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005 Apr;28(4):499-521. [Abstract][Full Text]
236. Collop NA, Anderson WM, Boehlecke B, et al; Portable Monitoring Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J Clin Sleep Med. 2007 Dec 15;3(7):737-47.[Abstract][Full Text]
237. Powell NB, Zonato AI, Weaver EM, et al. Radiofrequency treatment of turbinate hypertrophy in subjects using continuous positive airway pressure: a randomized, double-blind, placebo-controlled clinical pilot trial. Laryngoscope. 2001 Oct;111(10):1783-90.[Abstract]
238. Zonato AI, Bittencourt LR, Martinho FL, et al. Upper airway surgery: the effect on nasal continuous positive airway pressure titration on obstructive sleep apnea patients. Eur Arch Otorhinolaryngol. 2006 May;263(5):481-6. [Abstract]
239. Tietjens JR, Claman D, Kezirian EJ, et al. Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc. 2019 Jan 8;8(1):e010440.[Abstract][Full Text]
240. Coker RK, Armstrong A, Church AC, et al. BTS clinical statement on air travel for passengers with respiratory disease. Thorax. 2022 Apr;77(4):329-50.[Abstract][Full Text]
Key Articles
Other Online Resources
Referenced Articles
Sign in to access our clinical decision support tools